Med. Pro Praxi 2008; 5(4): 150-154

Farmakologická léčba fibrilace síní

doc. MUDr. Petr Heinc Ph.D
I. interní klinika FN a LF UP Olomouc

Fibrilace síní je nejčastější setrvalou arytmií a nezávislým rizikovým faktorem pro vznik CMP v důsledku tromboembolizmu. Je podána strategie léčby a doporučení farmakologické léčby kontroly frekvence, kontroly rytmu a prevence tromboembolie.

Keywords: fibrilace síní, rizikové faktory, strategie farmakologické léčby, kontrola frekvence, kontrola rytmu, prevence tromboembolie

Published: July 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Heinc P. Farmakologická léčba fibrilace síní. Med. praxi. 2008;5(4):150-154.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Agarwal AK, Venugopalan P. Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy. Eur J Heart Fail 2001; 3: 437-340. Go to original source... Go to PubMed...
    2. Anderson JL, Prystowsky EN. Sotalol: an important new antiarrhythmic. Am Heart J 1999; 137: 388-409. Go to original source... Go to PubMed...
    3. Antonielli E, Pizzuti A, Bassignana A et al. Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. Am J Cardiol 1999; 84: 1092-1110. Go to original source... Go to PubMed...
    4. Azpitarte J, Alvarez M, Baun O et al. Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study. Eur Heart J 1997; 18: 1649-1654. Go to original source... Go to PubMed...
    5. Black IW, Fatkin D, Sagar KB et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation 1994; 89: 2509-2513. Go to original source... Go to PubMed...
    6. Botto GL, Capucci A, Bonini W et al. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. Int J Cardiol 1997; 58: 55-61. Go to original source... Go to PubMed...
    7. Capucci A, Lenzi T, Boriani G et al. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 1992; 70: 69-72. Go to original source... Go to PubMed...
    8. Carlsson J, Miketic S, Windeler J et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003; 41: 1690-1696. Go to original source... Go to PubMed...
    9. Clemo HF, Wood MA, Gilligan DM et al. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol (1998) 81: 594-8. Go to original source... Go to PubMed...
    10. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation (2004) 109: III39-III43. Go to original source...
    11. Farshi R, Kistner D, Sarma JS et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J Am Coll Cardiol 1999; 33: 304-310. Go to original source... Go to PubMed...
    12. Fatkin D, Kuchar DL, Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for" atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994; 23: 307-316. Go to original source... Go to PubMed...
    13. Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFf) study groups. Neurology 1999; 53: 1319-1327. Go to original source... Go to PubMed...
    14. Gronefeld GC, Lilienthal J, Kuck KH et al. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. Eur Heart J 2003; 24: 1430-1436. Go to original source... Go to PubMed...
    15. Hagens VE, Ranchor AV, Van SE et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol 2004; 43: 241-247. Go to original source... Go to PubMed...
    16. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF IIII clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 1999; 30: 1223-1229. Go to original source... Go to PubMed...
    17. Hirsh J, Warkentin TE, Shaughnessy SG et al. Heparin and low molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119: 64S-94S. Go to original source... Go to PubMed...
    18. Kannel WB, Abbot RD, Savage DD et al. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982; 306: 1018-1022. Go to original source... Go to PubMed...
    19. Kay GN, Ellenbogen KA, Giudici M et al. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol (1998) 2: 121-135. Go to original source... Go to PubMed...
    20. Komatsu T, Nakamura S, Suzuki O et al. Long-term efficacy of combination therapy using antiarrhythmic agents and angiotensin converting enzyme inhibitor in patients with paroxysmal and persistent atrial fibrillation: importance of the timing of administration. J Cardiol 2003; 41: 73-80.
    21. Krahn AD, Manfreda J, Tate RB et al. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study: Am J. Med 1995; 98: 476-484. Go to original source... Go to PubMed...
    22. Lake FR, Cullen KJ, deKlerk NH et al. Atrial fibrillation and mortality in an elderly population. Aust NZ J Med 1989; 19: 321-326. Go to original source... Go to PubMed...
    23. Lévy S, Breithardt G, Campbell RWF et al. Atrial fibrillation: current knowledge and recommendations for management. Eur Heart J 1998; 19: 1294-1320. Go to original source... Go to PubMed...
    24. Lukl J, Řezáčová M, Černošek B, Heinc P. Užití amiodaronu v léčbě míhání síní odolného proti digoxinu. I. Schopnost amiodaronu převést míhání síní na sinusový rytmus a jeho krátkodobé udržení. Vnitř Lék 1985; 31: 177-181. Go to PubMed...
    25. Lundstrom T. Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil. J Am Coll Cardiol 1990; 16: 86-90. Go to original source... Go to PubMed...
    26. Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation 2000; 101: 207-213. Go to original source... Go to PubMed...
    27. Narayan SM, Cain ME, Smith JM. Atrial fibrillation. Lancet 1997; 50: 943-950. Go to original source... Go to PubMed...
    28. Olshansky B, Rosenfeld LE, Warner AL et al. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol 2004; 43: 1201-1208. Go to original source... Go to PubMed...
    29. Opolski G, Torbicki A, Kosior DA et al. Rate control vs. rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 2004; 126: 476-486. Go to original source... Go to PubMed...
    30. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group. N Engl J Med 1995; 333: 5-10.
    31. Pedersen OD, Bagger H, Kober L et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999; 100: 376-380. Go to original source... Go to PubMed...
    32. Pound EM, Kang JX, Leaf A. Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J Lipid Res 2001; 42: 346-351. Go to original source...
    33. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med 1992; 116: 6-12.
    34. Psaty BM., Manolio TA., Kuller LH et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461. Go to original source... Go to PubMed...
    35. Rationale: design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation: Congestive Heart Failure (AF-CHF) trial. Am Heart J 2002; 144: 597-607. Go to original source... Go to PubMed...
    36. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-1457.
    37. Sherman DG, Kim SG, Boop BS et al. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study. Arch Intern Med 2005; 165: 1185-1191. Go to original source... Go to PubMed...
    38. Siu CW, Lau CP, Tse HF. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 2003; 92: 1343-1345. Go to original source... Go to PubMed...
    39. Suttorp MJ, Kingma JH, Jessurun ER, Lie AII, van Hemel NM, Lie KI. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990; 16: 1722-1727. Go to original source... Go to PubMed...
    40. Tamariz LJ, Bass EB. Pharmacological rate control of atrial fibrillation. Cardiol Clin 2004; 22: 35-45. Go to original source... Go to PubMed...
    41. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators. Arch Intern Med 1997; 157: 1237-1240.
    42. Ueng KC, Tsai TP, Yu WC et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J 2003; 24: 2090-2098. Go to original source... Go to PubMed...
    43. van Den Berg MP, Crijns HJ, van Veldhuisen DJ et al. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail 1995; 1: 355-363. Go to original source... Go to PubMed...
    44. van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840. Go to original source... Go to PubMed...
    45. van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840. Go to original source... Go to PubMed...
    46. Vardas PE, Kochiadakis GE, Igoumenidis NE, Tsatsakis AM, Simantirakis EN, Chlouverakis GI. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study. Chest 2000; 117: 1538-1545. Go to original source... Go to PubMed...
    47. Weerasooriya R, Davis M, Powell A et al. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol 2003; 41: 1697-1702. Go to original source... Go to PubMed...
    48. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.